1. NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes
   Ruobing Leng et al, 2022, Frontiers in Oncology CrossRef
2. Ketogenic Diet and Breast Cancer: Recent Findings and Therapeutic Approaches
   Alfio Giuseppe Urzì et al, 2023, Nutrients CrossRef
3. BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients
   Salma Wahabi Alzahabi et al, 2024, Egyptian Journal of Medical Human Genetics CrossRef
4. Public neoantigens in breast cancer immunotherapy (Review)
   Natthaporn Sueangoen et al, 2024, International Journal of Molecular Medicine CrossRef
5. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC
   Qiaonan Guo et al, 2022, Disease Markers CrossRef
6. Methylation‑sensitive restriction enzyme‑droplet digital PCR assay for the one‑step highly sensitive analysis of DNA methylation hotspots
   Giuseppe Gattuso et al, 2024, International Journal of Molecular Medicine CrossRef
7. BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation
   Sihan Chen et al, 2022, Frontiers in Oncology CrossRef
8. MicroRNAs as Potential Biomarkers in Gynecological Cancers
   Joanna Miśkiewicz et al, 2023, Biomedicines CrossRef
9. Identification of CXCL13 as a Promising Biomarker for Immune Checkpoint Blockade Therapy and PARP Inhibitor Therapy in Ovarian Cancer
   Yue Ding et al, 2024, Molecular Biotechnology CrossRef
10. Polygenic Risk Score Predicts Modified Risk in BRCA1 Pathogenic Variant c.4035del and c.5266dup Carriers in Breast Cancer Patients
    Egija Berga-Švītiņa et al, 2023, Cancers CrossRef
11. BRCA Mutations and Fertility Preservation
    Joana Dias Nunes et al, 2023, International Journal of Molecular Sciences CrossRef
12. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer
    Baohong Jiang et al, 2022, Disease Markers CrossRef
13. Identification and Validation of Autophagy-Related Genes in Primary Ovarian Insufficiency by Gene Expression Profile and Bioinformatic Analysis
    Siji Lv et al, 2022, Analytical Cellular Pathology CrossRef
14. HIPEC for gynaecological malignancies: A last update (Review)
    Chrysoula Margioula‑Siarkou et al, 2023, Medicine International CrossRef
15. Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer
    Xianwen Hu et al, 2022, Frontiers in Oncology CrossRef
16. Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes
    Daniele Marrelli et al, 2022, Cancers CrossRef
17. ATAD2 Upregulation Promotes Tumor Growth and Angiogenesis in Endometrial Cancer and Is Associated with Its Immune Infiltration
    Can Wang et al, 2022, Disease Markers CrossRef
18. Vitamin D and microRNAs: Role in the pathogenesis and prognosis of breast cancer (Review)
    Luca Falzone et al, 2023, International Journal of Epigenetics CrossRef
19. Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors
    Gyongyver Szentmartoni et al, 2024, Biomedicines CrossRef
20. Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer
    Kai Wang et al, 2022, Disease Markers CrossRef